Quest Diagnostics Inc
Research Quest Diagnostics Inc (DGX) on Bullrun: valuation model: 7.4% overvalued, market cap USD 25.41B, P/E 24.5, dividend yield 1.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDGX
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyUSD
- Valuation signal7.4% overvalued
- Market capUSD 25.41B
- P/E24.5
- Dividend yield1.5%
- Financial periodQ2 2026
- RevenueUSD 3.04B
- Net incomeUSD 320.00M
- Free cash flowUSD 459.00M
- Gross margin33.7%
Valuation Snapshot
Bullrun's latest valuation model marks Quest Diagnostics Inc as 7.4% overvalued; latest market cap is USD 25.41B; P/E is 24.5; dividend yield is 1.5%.
Peer valuation comparison
Latest P/E is 24.5x versus a Healthcare sector median of 24.61x.
Latest dividend yield is 1.45% versus a Healthcare sector median of 1.84% (21.2% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 11.04B | USD 992.00M | USD 1.36B | 33.2% | 8.75 | USD 420.00M | USD 5.67B | USD 7.17B |
| FY2024 | USD 9.87B | USD 871.00M | USD 909.00M | 32.9% | 7.69 | USD 549.00M | USD 6.22B | USD 6.78B |
| FY2023 | USD 9.25B | USD 854.00M | USD 864.00M | 33.0% | 7.49 | USD 686.00M | USD 4.71B | USD 6.31B |
| FY2022 | USD 9.88B | USD 946.00M | USD 1.31B | 34.7% | 7.97 | USD 315.00M | USD 3.98B | USD 5.89B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 25.41B | 24.5 | 1.5% | 3.38 |
| 2025 | 2025-12-31 | USD 19.13B | 19.8 | 1.8% | 3.15 |
| 2024 | 2024-12-31 | USD 16.69B | 19.6 | 2.0% | 2.96 |
| 2023 | 2023-12-29 | USD 15.50B | 20.7 | 2.0% | 2.79 |
| 2022 | 2022-12-30 | USD 17.82B | 15.4 | 1.7% | 2.6 |
| 2021 | 2021-12-31 | USD 20.59B | 11.1 | 1.4% | 2.42 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3.38 USD, yield 1.5%.
| Year | Dividends/share |
|---|---|
| FY2025 | 3.15 USD |
| FY2024 | 2.96 USD |
| FY2023 | 2.79 USD |
| FY2022 | 2.6 USD |
About Quest Diagnostics Inc
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.
ETFs that hold Quest Diagnostics Inc
Quest Diagnostics Inc is one of the ten largest holdings of 4 ETFs that investors in Europe can buy, most traded first:
| ETF | Weight | TER |
|---|---|---|
| UBS Factor MSCI USA Low Volatility UCITS ETF USD dis | 1.08% | 0.18% |
| UBS Factor MSCI USA Low Volatility UCITS ETF hEUR acc | 1.01% | 0.21% |
| Global X Telemedicine & Digital Health ETF A | 4.16% | 0.68% |
| Global X Telemedicine & Digital Health ETF D | 3.78% | 0.68% |
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Quest Diagnostics Inc overvalued or undervalued?
Bullrun's valuation model currently marks Quest Diagnostics Inc as 7.4% overvalued.
What is Quest Diagnostics Inc's market cap?
Quest Diagnostics Inc's market capitalization is USD 25.41B.
What is Quest Diagnostics Inc's P/E ratio?
Quest Diagnostics Inc's price-to-earnings (P/E) ratio is 24.5.
Does Quest Diagnostics Inc pay a dividend?
Quest Diagnostics Inc has a dividend yield of 1.5%.
What does Quest Diagnostics Inc do?
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services.